Premium
Addressing racial/ethnic disparities in cancer clinical trials: Everyone has a role to play
Author(s) -
Habr Dany,
Ferdinand Roxanne
Publication year - 2021
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.33600
Subject(s) - medicine , ethnic group , clinical trial , cancer , cancer incidence , diversity (politics) , health equity , gerontology , pathology , public health , sociology , anthropology
Cancer disproportionately impacts racial/ethnic minority groups, yet they remain underrepresented in cancer clinical trials. This commentary highlights strategies for consideration by the pharmaceutical industry to ensure diversity in therapeutic clinical trials that reflects known incidence and burden of cancer and allows appropriate interpretation of risk/benefit with emerging therapies.